Trinity Biotech PLC (TWU) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Trinity Biotech PLC Company Snapshot

Business Description:

Trinity Biotech PLC operates in the Diagnostic substances sector. Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a significant provider of raw materials to the life sciences industry. Trinity Biotech markets its portfolio of over 500 products to customers in 75 countries worldwide. Trinity Biotech markets its products in the United States and the rest of the world through a combination of direct selling and a network of national and international distributors. It has established direct sales forces in the United States, Germany, France and the United Kingdom. In May 2010, the Company disposed of its coagulation business to the Stago Group.

Stock Performance Chart for Trinity Biotech PLC

Stock Data:

Recent Stock Performance:

Current Price (11/2/2007): 1.46
(Figures in Euro)

1 Week	n/a	13 Weeks	n/a

4 Weeks	n/a	52 Weeks	n/a

Trinity Biotech PLC Key Data:

Ticker:	TWU	Country:	IRELAND

Exchanges:	OTH DUB	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Diversified Drugs, Cosmetics, & Health Care

2010 Sales	67,903,891 (Year Ending Jan 2011).	Employees:	452

Currency:	Euro	Market Cap:	124,030,196

Fiscal Yr Ends:	December	Shares Outstanding:	84,952,189

Share Type:	Ordinary	Closely Held Shares:	17,794,772

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.